Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
Background: Cystinosis is a rare genetic disorder characterized by the accumulation of cystine crystals in several tissues and organs causing, among others, severe eye symptoms. The high instability of cysteamine eye drops makes it difficult to develop formulations with an acceptable shelf life to b...
Saved in:
Main Authors: | Ana Castro-Balado (Author), Andrea Cuartero-Martínez (Author), Hugo Pena-Verdeal (Author), Gonzalo Hermelo-Vidal (Author), Anja Schmidt (Author), Belén Montero (Author), Manuela Hernández-Blanco (Author), Irene Zarra-Ferro (Author), Miguel González-Barcia (Author), Cristina Mondelo-García (Author), María Jesús Giráldez (Author), Eva Yebra-Pimentel (Author), Francisco J. Otero-Espinar (Author), Anxo Fernández-Ferreiro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
by: Ana Castro-Balado, et al.
Published: (2022) -
Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
by: Ana Castro-Balado, et al.
Published: (2020) -
Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis
by: Anxo Fernández-Ferreiro, et al.
Published: (2017) -
Erratum found in «Farmacia Hospitalaria. 2020;44(4):149-57»
by: Ana Castro-Balado, et al.
Published: (2021) -
Ocular Biodistribution Studies using Molecular Imaging
by: Ana Castro-Balado, et al.
Published: (2019)